STAT3 and cancer: Inhibition of STAT3 in mice lacking S1P lyase activity with chemically induced colitis-associated cancer resulted in the reduction of inflammatory response and decreased incidence of colon tumors, which indicates that pro-inflammatory and pro-tumorigenic effects of gut S1P lyase disruption are mediated by STAT3 activation [114].